Australian Health Innovators’ Journey to US Market Success
Reflections from AusBiotech 2024
Drawing from recent conversations with Australian healthcare innovators, including discussions at AusBiotech 2024, Dr. Peter Cronin explores the evolving challenges of US market entry. He shares insights on how companies are moving beyond traditional approaches to embrace data-driven, patient-centric strategies for global success.
Accelerating Effectiveness of Clinical Trials with Patient-centric Intelligence
Patient-centric intelligence can be utilised in early phases of pharma product development lifecycle for identification of unmet medical needs and opportunities and to improve the success rate of clinical trials, leading to faster drug development, successful market entry and treatments reaching patients sooner.
